Julie M. Cunningham
YOU?
Author Swipe
View article: Evaluating cell type deconvolution in FFPE breast tissue: application to benign breast disease
Evaluating cell type deconvolution in FFPE breast tissue: application to benign breast disease Open
Transcriptome profiling using RNA sequencing (RNA-seq) of bulk formalin-fixed paraffin-embedded (FFPE) tissue blocks is a standard method in biomedical research. However, when used on tissues with diverse cell type compositions, it yields …
View article: Supplementary Table 3 from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis
Supplementary Table 3 from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis Open
Supplementary Table 3: Case-only comparisons between BRCA variant carriers and non-carriers, high grade serous cancer and endometrioid/clear cell carcinomas
View article: Supplementary Table 1 from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis
Supplementary Table 1 from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis Open
Supplementary Table 1: Characteristics of the contributing studies
View article: Supplementary Table 2 from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis
Supplementary Table 2 from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis Open
Supplementary Table 2: Case-only comparisons between BRCA variant carriers and non-carriers, all invasive cancers
View article: Supplementary Table 2 from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis
Supplementary Table 2 from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis Open
Supplementary Table 2: Case-only comparisons between BRCA variant carriers and non-carriers, all invasive cancers
View article: Supplementary Methods from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis
Supplementary Methods from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis Open
Supplementary Methods for multiple imputation and sensitivity analysis
View article: Data from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis
Data from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis Open
Background:Women with an inherited pathogenic variant in BRCA1 or BRCA2 have a greatly increased risk of developing ovarian cancer, but the importance of behavioral factors is less clear. We used a case-only design to compare the magnitude…
View article: Supplementary Table 3 from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis
Supplementary Table 3 from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis Open
Supplementary Table 3: Case-only comparisons between BRCA variant carriers and non-carriers, high grade serous cancer and endometrioid/clear cell carcinomas
View article: Supplementary Table 1 from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis
Supplementary Table 1 from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis Open
Supplementary Table 1: Characteristics of the contributing studies
View article: Supplementary Methods from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis
Supplementary Methods from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis Open
Supplementary Methods for multiple imputation and sensitivity analysis
View article: Data from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis
Data from Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis Open
Background:Women with an inherited pathogenic variant in BRCA1 or BRCA2 have a greatly increased risk of developing ovarian cancer, but the importance of behavioral factors is less clear. We used a case-only design to compare the magnitude…
View article: Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease Open
Survival from ovarian cancer depends on the resection status after primary surgery. We performed genome-wide association analyses for resection status of 7705 ovarian cancer patients, including 4954 with high-grade serous carcinoma (HGSOC)…
View article: Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis
Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis Open
Background: Women with an inherited pathogenic variant in BRCA1 or BRCA2 have a greatly increased risk of developing ovarian cancer, but the importance of behavioral factors is less clear. We used a case-only design to compare the magnitud…
View article: Genomic epidemiology reveals the dominance of Hennepin County in the transmission of SARS-CoV-2 in Minnesota from 2020 to 2022
Genomic epidemiology reveals the dominance of Hennepin County in the transmission of SARS-CoV-2 in Minnesota from 2020 to 2022 Open
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had an unprecedented impact on human health and highlights the need for genomic epidemiology studies to increase our understanding of virus evolution and spread and to inform…
View article: Trends in COVID-19 Infections during Four Surges in Bexar County, Texas
Trends in COVID-19 Infections during Four Surges in Bexar County, Texas Open
Background: Bexar County, Texas has experienced four COVID-19 surges during the pandemic. This study investigates trends in COVID-19 infections over the course of pandemic. The objective is to describe the association of COVID-19 infection…
View article: Supplementary Table 1 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer
Supplementary Table 1 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer Open
PDF file - 20K
View article: Supplementary Table 3 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer
Supplementary Table 3 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer Open
PDF file - 47K
View article: Supplementary Methods 1 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
Supplementary Methods 1 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma Open
Supplementary Methods 1: The original 60 CpG loci defining methylation-based subtypes, and the approximation method for methylation signature
View article: Supplementary Figure 2 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
Supplementary Figure 2 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma Open
Supplementary Figure 2: No Association between Methylation Signature and Baseline Clinical Factors
View article: Supplementary Figure 3 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
Supplementary Figure 3 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma Open
Supplementary Figure 3: Immune Analysis
View article: Supplementary Table 6 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
Supplementary Table 6 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma Open
Supplementary Table 6: Multivariate Modeling of Time to Recurrence/Death Among Studies with Gene Expression Data
View article: Supplementary Table 2 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
Supplementary Table 2 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma Open
Supplementary Table 2: CpGs That Defined Previously Reported Methylation Subtypes Using a Semi-Supervised Clustering Approach
View article: Supplementary Table 5 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
Supplementary Table 5 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma Open
Supplementary Table 5: Modeling of Time to Recurrence/Death Among Studies with Gene Expression Data, excluding data from Previously Published Participants
View article: Supplementary Table 4 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
Supplementary Table 4 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma Open
Supplementary Table 4: Multivariate Modeling of Methylation Signature Among Studies with Multiple Datatypes
View article: Supplementary Table 2 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
Supplementary Table 2 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma Open
Supplementary Table 2: CpGs That Defined Previously Reported Methylation Subtypes Using a Semi-Supervised Clustering Approach
View article: Supplementary Table 1 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
Supplementary Table 1 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma Open
Supplementary Table 1: Characteristics of Study Participants with High Grade Serous Tubo-Ovarian Carcinoma by Contributing Study
View article: Supplementary Table 5 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
Supplementary Table 5 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma Open
Supplementary Table 5: Modeling of Time to Recurrence/Death Among Studies with Gene Expression Data, excluding data from Previously Published Participants
View article: Supplementary Table 2 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer
Supplementary Table 2 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer Open
PDF file - 46K
View article: Supplementary Table 1 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
Supplementary Table 1 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma Open
Supplementary Table 1: Characteristics of Study Participants with High Grade Serous Tubo-Ovarian Carcinoma by Contributing Study